Accelerate Diagnostics, Inc. announced preliminary unaudited revenue results for the year ended December 31, 2023. Preliminary revenue was approximately $12.1 million for the year, compared to $12.8 million in the prior year. While year-over-year revenues for consumable products increased by approximately 5%, overall annual revenue was down year-over-year due to a challenging capital sales environment in all sales regions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8802 USD | +1.17% | -4.82% | -77.55% |
May. 08 | Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M | MT |
May. 08 | Transcript : Accelerate Diagnostics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-77.55% | 19.07M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- AXDX Stock
- News Accelerate Diagnostics, Inc.
- Accelerate Diagnostics, Inc. Announces Preliminary Unaudited Revenue Results for the Year Ended December 31, 2023